Alterations of the vascular basal lamina in the cerebral cortex in drug abuse: a combined morphometric and immunohistochemical investigation.
In drug abusers, white matter hyperintensities, perfusion deficits, and metabolic disturbances are detected by neuroimaging analyses in different brain regions. A specific pattern of involvement or a predominance of a specific brain region cannot be drawn. To examine changes of the cerebral microvasculature as a possible morphological substrate of the neuroimaging findings, brain specimens of 12 polydrug abusers and 8 controls were obtained at autopsy. The basal lamina of blood vessels from the frontal, temporal, parietal, and occipital lobes was analysed by means of immunohistochemistry for collagen type IV. The numerical density of vessels was determined in the gray and white matter, and their staining intensity was rated using a three-point scale. In the gray and white matter of polydrug abusers, the number of vessels showing strong immunoreactivity for collagen type IV was significantly reduced, whereas the number of vessels with mild and moderate immunoreactivity was increased as compared to controls. The total numerical density of vessels was not significantly changed. Our results show a significant reduction in immunoreactivity for collagen type IV in the brains from polydrug abusers compared to controls, which may be due to a thinning of the basal lamina of cerebral vessels. The data of the present study show morphological changes of the basal lamina in the brain of polydrug abusers, which might represent the morphological substrate of a disturbed blood-brain barrier. However, it remains yet to be established if the observed changes are responsible for the alterations seen in different neuroimaging analyses and which drug might be of major pathogenetic significance.
Büttner
Andreas
A
Institute of Legal Medicine, Ludwig-Maximilians University, Frauenlobstrasse 7a, 80337 Munich, Germany. andreas.buettner@rechts.med.uni-muenchen.de
Kroehling
Claus
C
Mall
Gita
G
Penning
Randolph
R
Weis
Serge
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D001485:Basement Membrane / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D002540:Cerebral Cortex / Q000378:metabolism* / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D024141:Collagen Type IV / Q000378:metabolism*; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism / Q000473:pathology; D006801:Humans; D013287:Illicit Drugs; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009778:Occipital Lobe / Q000378:metabolism / Q000473:pathology; D010296:Parietal Lobe / Q000378:metabolism / Q000473:pathology; D019966:Substance-Related Disorders / Q000378:metabolism* / Q000473:pathology*; D013702:Temporal Lobe / Q000378:metabolism / Q000473:pathology
D024141:Collagen Type IV; D013287:Illicit Drugs